I am 55, male. How do I manage my T2D and CKD?

Question

Hi doctor,

I am a 55-year-old man with type 2 diabetes for the past 8 years, currently on Metformin and Glimepiride. My recent HbA1c is 8.6%, and my fasting blood glucose averages around 160 mg/dL. Despite medication, my blood sugar remains uncontrolled. I also have hypertension (BP: 150/95 mmHg) and take Amlodipine and Losartan.

Additionally, I was diagnosed with diabetic neuropathy last year; nerve conduction studies showed reduced sensory response in both feet. I experience tingling, burning pain, and numbness, especially at night. My LDL cholesterol is elevated at 140 mg/dL, and my triglycerides are 220 mg/dL. My BMI is 31.4, and I have gained 8 pounds in the last six months.

I also have stage 2 chronic kidney disease, with an eGFR of 68 mL/min/1.73 m² and urine microalbumin at 120 mg/g. I often feel tired and have difficulty sleeping. Should my diabetes treatment be modified, and how can my other conditions be better managed alongside it?

Please help.

Answer 1

Hi,

Welcome to icliniq.com.

I understand your concern.

You are a 55-year-old man with an 8-year history of type 2 diabetes, currently on Metformin and Glimepiride. Despite this, your HbA1c (glycated hemoglobin) remains elevated at 8.6 percent, and your fasting glucose averages around 160 mg/dL, indicating suboptimal control.

Additionally, you have stage 2 chronic kidney disease (eGFR [estimated glomerular filtration rate] 68 mL/min/1.73 m² with urine microalbumin at 120 mg/g), hypertension (150/95 mmHg despite Amlodipine and Losartan), diabetic neuropathy (with burning, tingling, and numbness in both feet), dyslipidemia (low- density lipoprotein 140 mg/dL, triglycerides 220 mg/dL), and obesity (body mass index 31.4 with a recent weight gain of eight pounds). You also experience fatigue and poor sleep quality, which may be multifactorial.

Given this background, treatment intensification is warranted. It is advisable to discontinue Glimepiride due to its risk of hypoglycemia and weight gain, and instead introduce a GLP-1 (glucagon-like peptide) receptor agonist such as Semaglutide. This will help reduce blood sugar, support weight loss, and offer cardiovascular and kidney protection. Additionally, adding an SGLT2 (sodium-glucose cotransporter-2) inhibitor like Empagliflozin is strongly recommended, as it provides further blood sugar control and protects both heart and kidney health. Metformin can be continued, provided kidney function remains stable.

Your blood pressure is above the recommended target for diabetic patients with kidney disease, which should be below 130/80 mmHg. Losartan should be titrated to its maximum dose if not already, and if needed, a low-dose diuretic such as Chlorthalidone can be added.

For your lipid profile, a high-intensity statin such as Atorvastatin (40 to 80 mg daily) is essential to reduce LDL (low-density lipoprotein) below 70 mg/dL. If triglycerides remain elevated, Fenofibrate or omega-3 fatty acids may be added.

For your neuropathy symptoms, medications such as Duloxetine or Pregabalin can be initiated to relieve nerve pain, especially at night, and may also help with sleep. Supplements like methylcobalamin or alpha-lipoic acid may offer additional support.

Your weight and recent gain indicate a need for lifestyle modification with a structured, kidney-friendly, low-carbohydrate diet and regular physical activity, preferably at least 30 minutes of walking or low-impact exercise daily. Semaglutide will also aid in weight reduction.

Given your symptoms of fatigue and sleep disturbance, evaluation for obstructive sleep apnea (especially if snoring is present) and screening for depression are advisable. Both conditions can contribute to poor glycemic control and should be addressed.

I hope this has helped you.

Please feel free to reach out to me again for further queries.

Thank you.